While headache is reported as an adverse reaction, it is not listed among the most common adverse events in the FDA Prescribing Information for Ozempic
Failure to Warn Allegations in Ozempic Lawsuits The lawsuits surrounding Novo Nordisk, the manufacturer of Ozempic, have brought significant attention to the concept of failure to warn. At the core of these legal claims, plaintiffs argue that the company did not adequately inform consumers about the risks of gallbladder complications, including gallstones and acute gallbladder disease, associated with their medication
However, he said that semaglutide is not licensed for the treatment of PCOS
Stunkards statement sounds somewhat critical
The susceptibility of neurons to mitochondrial dysfunction may be explained by the high dependence of neurons on oxidative phosphorylation (69)
This mechanism opens research applications that single or dual agonists dont address